Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
BIIB.OQ - Biogen Inc
Biogen Inc to Present at the American Neurological Association Virtual Meeting
Oct 17, 2021 / 08:20PM GMT
=====================
Conference Call Participants
=====================
* Timothy Miller
=====================
Presentation
--------------------------------------------------------------------------------
Timothy Miller, [1]
--------------------------------------------------------------------------------
My name is Tim Miller. And on behalf of Merit Cudkowicz and the VALOR Working Group, I am delighted to present today results from the Phase III VALOR study and its open-label extension evaluating the clinical efficacy and safety of tofersen in adults with ALS and confirmed SOD1 mutation.
This study was sponsored by Biogen and uses antisense oligonucleotides developed by Ionis Pharmaceuticals, so some relevant disclosures. I serve on an advisory board and received clinical support for -- from Biogen and have a licensing agreement with and consulting for Ionis Pharmaceuticals, and you
Trustpilot
